Sort
21,453 grants matching “tuberculosis”
Calcium Signaling in MR1-Dependent Antigen Presentation
$231,000Elham Karamooz · Oregon Health & Science University · R21 · FY2020 · AI
Alteration of lipid A acyl chain length in Salmonella
$231,000Qingke Kong · Arizona State University-Tempe Campus · R21 · FY2012 · AI
A Xenopus tadpole alternative model to study innate-like T cell-mediated anti-mycobacterial immunity
$231,000Jacques Robert · University Of Rochester · R21 · FY2018 · AI
Systematic analysis of components of mycobacterial Mce transporters
$230,992Miriam S. Braunstein · Univ Of North Carolina Chapel Hill · R21 · FY2018 · AI
Development of new M. tuberculosis MmpL3 inhibitors
$230,979Robert B Abramovitch · Michigan State University · R21 · FY2021 · AI
Defining resistance and tolerance mechanisms in hyper-susceptible mice during M. tuberculosis infection
$230,979Andrew Olive · Michigan State University · R21 · FY2021 · AI
Spatial organization of mycobacterial cell wall biosynthesis
$230,935Yasu S Morita · University Of Massachusetts Amherst · R21 · FY2020 · AI
Mechanisms of MHCII expression and CD4+ T cell activation during Chlamydia trachomatis infection
$230,884Andrew Olive · Michigan State University · R21 · FY2021 · AI
HIGHER PLANTS AS SOURCE OF ANTITUBERCULOSIS ACTIVITY
$230,840University Of Puerto Rico Med Sciences · S06 · FY2002 · GM
INDUCED PRODUCTION OF ANTIMYCOBACTERIAL COMPOUNDS IN MARINE BACTERIA
$230,840California State University San Marcos · S06 · FY2002 · GM
HIGHER PLANTS AS SOURCE OF ANTITUBERCULOSIS ACTIVITY
$230,840University Of Puerto Rico Med Sciences · S06 · FY2001 · GM
INDUCED PRODUCTION OF ANTIMYCOBACTERIAL COMPOUNDS IN MARINE BACTERIA
$230,840California State University San Marcos · S06 · FY2002 · GM
HIGHER PLANTS AS SOURCE OF ANTITUBERCULOSIS ACTIVITY
$230,840University Of Puerto Rico Med Sciences · S06 · FY2002 · GM
INDUCED PRODUCTION OF ANTIMYCOBACTERIAL COMPOUNDS IN MARINE BACTERIA
$230,840California State University San Marcos · S06 · FY2001 · GM
New Tools for the interpretation of Pathogen Genomic Data with a focus on Mycobacterium tuberculosis
$230,806Maha Farhat · Massachusetts General Hospital · K01 · FY2015 · ES
Gonococcal resistance to peroxynitrite
$230,750Virginia L Clark · University Of Rochester · R21 · FY2009 · AI
Comparative Effectiveness of Rapid TB Diagnostics in Uganda
$230,747David Wesley Dowdy · Johns Hopkins University · R21 · FY2013 · AI
BU Summer Institute for Research Education in Biostatistics and Data Science
$230,657Helen E. Jenkins · Boston University Medical Campus · R25 · FY2024 · AI
Unraveling the Origin of Pyrazinamide's Synergy with other anti-TB Drugs
$230,610Dean C Crick · Colorado State University · R21 · FY2015 · AI
CDI MEDIATED CONTROL OF INFECTION AND AUTOIMMUNITY
$230,565University Of Chicago · R01 · FY2000 · AI
Project 2: Fate and Effects of Inhaled ENMs in the Lung
$230,439Kian Fan Chung · University Of Southern California · U19 · FY2010 · ES
Targeting SecA1 of Mycobacterium tuberculosis for Novel Drug Development
$230,399Miriam S. Braunstein · Univ Of North Carolina Chapel Hill · R21 · FY2015 · AI
PE and PPE Function
$230,325Sarah M Fortune · Harvard School Of Public Health · R21 · FY2007 · AI
Ultrasensitive Detection of Urine LAM for Point-of-Care Diagnosis of All Forms of Tuberculosis
$230,284Peter Wagner · Fluxus, Inc. · R43 · FY2021 · GH
Tuberculosis Elimination and Laboratory Cooperative Agreement (CoAg)
$230,253Basley Carlisle · South Carolina Department Of Public Health · U52 · FY2016 · PS